Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,892 | -2,532 | -2,813 | -3,163 | -1,899 |
| Depreciation Amortization | 54 | 233 | 176 | 120 | 61 |
| Accounts receivable | -518 | 657 | 899 | 967 | 1,078 |
| Other Working Capital | -725 | -664 | -351 | 1,251 | 986 |
| Other Operating Activity | 4,999 | -5,303 | -3,556 | -1,823 | -1,063 |
| Operating Cash Flow | $-1,082 | $-7,609 | $-5,645 | $-2,648 | $-837 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -13 | -40 | -40 | -39 | -22 |
| Investing Cash Flow | $-13 | $-40 | $-40 | $-39 | $-22 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -2,750 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 5,826 | 0 | 0 | 0 |
| Financing Cash Flow | $N/A | $3,076 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 2,460 | 7,033 | 7,033 | 7,033 | 7,033 |
| End Cash Position | 1,365 | 2,460 | 1,348 | 4,346 | 6,174 |
| Net Cash Flow | $-1,095 | $-4,573 | $-5,685 | $-2,687 | $-859 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,082 | -7,609 | -5,645 | -2,648 | -837 |
| Capital Expenditure | -13 | -40 | -40 | -39 | -22 |
| Free Cash Flow | -1,095 | -7,649 | -5,685 | -2,687 | -859 |